Dbv technologies announces appointment of virginie boucinha as chief financial officer

Montrouge, france, october 16, 2023 dbv technologies announces appointment of virginie boucinha as chief financial officer dbv technologies (euronext: dbv – isin: fr0010417345 – nasdaq stock market: dbvt), a clinical-stage biopharmaceutical company, today announced the appointment of virginie boucinha as its chief financial officer, effective november 6, 2023. an experienced financial and operations executive, virginie will report directly to daniel tassÉ, chief executive officer, and serve as a member of the executive committee.
DBVT Ratings Summary
DBVT Quant Ranking